对ATP反应的纳米颗粒用于改进化学动力学治疗和双重饥饿治疗
Xiao-Fan Xu1, Jun-Tao Chen1, Qian Song1
1Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, Hunan Provincial University Key Laboratory for Environmental and Ecological Health, College of Chemistry, Xiangtan University, Xiangtan, 411105, PR China. lichunyan@xtu.edu.cn.
这项研究引入了用于增强癌症治疗的新型纳米粒子,将化学动力学疗法 (CDT) 与双重饥饿疗法 (ST) 结合起来. 这种双重作用的方法有效地抑制了瘤的生长,并提高了小鼠的生存率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症构成重大威胁,需要先进的治疗策略.
- 目前的化学动力学疗法 (CDT) 面临由于谷氨 (GSH) 过度表达和单一治疗方式的限制.
- 迫切需要改进和多模式的癌症治疗.
研究的目的:
- 开发基于ZIF的纳米粒子 (Cu2+-SK-GOD@ZIF-90) 用于增强化学动力学治疗和双重饥饿治疗.
- 研究结合CDT与癌症治疗的双重饥饿疗法的协同效应.
- 评估新型纳米颗粒在抑制瘤生长和提高生存率方面的有效性.
主要方法:
- 基于ZIF的纳米颗粒 (Cu2+-SK-GOD@ZIF-90) 的构建,封装铜离子 (Cu2+),什科宁 (SK) 和葡萄糖氧化酶 (GOD).
- 利用癌细胞中的纳米粒子降解 (ATP触发) 释放治疗剂.
- 研究了CDT中反应性氧物种 (ROS) 生成的芬顿式反应和双重饥饿疗法 (糖解抑制和葡萄糖阻塞) 的机制.
- 进行了体内实验以评估瘤抑制和存活率.
主要成果:
- Cu2+-SK-GOD@ZIF-90纳米粒子有效地在癌细胞内释放Cu2+,SK和GOD.
- 证实了CDT (通过Cu+催化H2O转化为OH) 和双ST (SK和GOD) 的协同作用.
- 消耗GSH和产生H2O2提高了CDT的疗效.
- *体内*研究显示,与对照组相比,在接受Cu2+-SK-GOD@ZIF-90治疗的小鼠中,显著抑制瘤生长和延长生存时间.
- 结合疗法表现出比单组分治疗更高的疗效.
结论:
- 开发的Cu2+-SK-GOD@ZIF-90纳米颗粒为协同癌症治疗提供了一个有前途的平台.
- 将化学动力学疗法与双重饥饿疗法相结合,为癌症治疗提供了一个有效和安全的策略.
- 这种方法克服了传统CDT的局限性,并为癌细胞提供了多方面的攻击.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
